The structure and reactivity of iron complexes of PMAH, which contains ligands that mimic the metal binding domain of iron bleomycin (FeBLM), have been studied using EPR spectroscopy. It had been reported [Guajardo, R. J.; Hudson, S. E.; Brown, S. J.; Mascharak, P. K. J. Am. Chem. Soc. 1993, 115, 7971] that iron complexes of PMAH can be activated to a ferric hydroperoxide, a structural analog by activated BLM, by various routes, including reaction of [Fe III PMA] 2+ with iodosylbenzene (PhIO), methanol, and base. We show that with or without PhIO, the latter reaction produces the methoxide complex of Fe III PMA, and not the hydroperoxide, contrary to the previous report. Thus, O−O bond formation through generation of a ferric hydroperoxide does not occur. The same methoxide complex ( g = 2.28, 2.18, 1.93) is generated by the addition of organic base and CH 3 OH, or LiOCH 3, to [Fe III PMA] 2+ . The formation of this [CH 3 O−Fe III PMA] + complex is confirmed by EPR titration of [Fe III PMA] 2+ with - OCH 3 and by electrospray mass spectrometry. In contrast, the hydroperoxy complex of Fe III PMA ( g = 2.22, 2.17, 1.94) can be generated by the reaction of [Fe III PMA] 2+ with hydrogen peroxide or during aerobic oxidation of [Fe II PMA] + . The present results illustrate that activation of iron complexes of PMAH occur under conditions that produce activated BLM and further demonstrate that reaction of [Fe III PMA] 2+ with PhIO and base does not provide a route to either a hypervalent iron species or a hydroperoxide intermediate. These results agree with the finding that PhIO cannot be used to generate activated bleomycin [Sam, J. W.; Tang, X.-J.; Magliozzo, R. S.; Peisach, J. J. Am. Chem. Soc. 1995, 117, 1012].
No takes yet. Share an insight, caveat, or question.
Lippai et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: